Jiangsu Hengrui Pharmaceuticals Co (FRA:0BO) E10: €0.10 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0BO Jiangsu Hengrui Pharmaceuticals Co Ltd FRA:0BO
71 GF Score
Price €6.35
GF Value €7.14
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Jiangsu Hengrui Pharmaceuticals Co E10?

Jiangsu Hengrui Pharmaceuticals Co FRA:0BO -0.78% 71 E10 is €0.10 as of Mar. 2026. GuruFocus rates FRA:0BO with a GF Score™ of 71/100 and a GF Value™ of €7.14 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jiangsu Hengrui Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.043. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.10 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jiangsu Hengrui Pharmaceuticals Co's average E10 Growth Rate was 12.50% per year. During the past 3 years, the average E10 Growth Rate was 10.20% per year. During the past 5 years, the average E10 Growth Rate was 10.00% per year. During the past 10 years, the average E10 Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jiangsu Hengrui Pharmaceuticals Co was 26.00% per year. The lowest was 9.00% per year. And the median was 24.30% per year.

As of today (2026-07-31), Jiangsu Hengrui Pharmaceuticals Co's current stock price is €6.35. Jiangsu Hengrui Pharmaceuticals Co's E10 for the quarter that ended in Mar. 2026 was €0.10. Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio of today is 63.50.

During the past 13 years, the highest Shiller PE Ratio of Jiangsu Hengrui Pharmaceuticals Co was 212.98. The lowest was 52.39. And the median was 91.75.


Jiangsu Hengrui Pharmaceuticals Co  (FRA:0BO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jiangsu Hengrui Pharmaceuticals Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6.35/0.10
=63.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jiangsu Hengrui Pharmaceuticals Co was 212.98. The lowest was 52.39. And the median was 91.75.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jiangsu Hengrui Pharmaceuticals Co E10 Related Terms


Jiangsu Hengrui Pharmaceuticals Co E10 Historical Data

* Premium members only.

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Hengrui Pharmaceuticals Co E10 Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.10

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.08 0.10 0.10 0.10

FRA:0BO vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Hengrui Pharmaceuticals Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Hengrui Pharmaceuticals Co's Shiller PE Ratio falls into.


FRA:0BO
71GF Score
Jiangsu Hengrui Pharmaceuticals Co Ltd FRA:0BO
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jiangsu Hengrui Pharmaceuticals Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jiangsu Hengrui Pharmaceuticals Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.043/116.3033*116.3033
=0.043

Current CPI (Mar. 2026) = 116.3033.

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.013 101.400 0.015
201609 0.013 102.400 0.015
201612 0.015 102.600 0.017
201703 0.018 103.200 0.020
201706 0.016 103.100 0.018
201709 0.016 104.100 0.018
201712 0.017 104.500 0.019
201803 0.019 105.300 0.021
201806 0.020 104.900 0.022
201809 0.020 106.600 0.022
201812 0.023 106.500 0.025
201903 0.025 107.700 0.027
201906 0.024 107.700 0.026
201909 0.027 109.800 0.029
201912 0.032 111.200 0.033
202003 0.027 112.300 0.028
202006 0.027 110.400 0.028
202009 0.031 111.700 0.032
202012 0.040 111.500 0.042
202103 0.030 112.662 0.031
202106 0.025 111.769 0.026
202109 0.032 112.215 0.033
202112 0.007 113.108 0.007
202203 0.027 114.335 0.027
202206 0.020 114.558 0.020
202209 0.024 115.339 0.024
202212 0.015 115.116 0.015
202303 0.026 115.116 0.026
202306 0.022 114.558 0.022
202309 0.024 115.339 0.024
202312 0.017 114.781 0.017
202403 0.027 115.227 0.027
202406 0.042 114.781 0.043
202409 0.024 115.785 0.024
202412 0.035 114.893 0.035
202503 0.038 115.116 0.038
202506 0.048 114.907 0.049
202509 0.023 115.471 0.023
202512 0.035 115.832 0.035
202603 0.043 116.303 0.043

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.10 mean?
Jiangsu Hengrui Pharmaceuticals Co (FRA:0BO) has a E10 of €0.10 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors.
Is Jiangsu Hengrui Pharmaceuticals Co's E10 too high?
Jiangsu Hengrui Pharmaceuticals Co's current E10 is €0.10. Overall, Jiangsu Hengrui Pharmaceuticals Co has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Hengrui Pharmaceuticals Co's E10 compare to ZTS and UTHR?
Jiangsu Hengrui Pharmaceuticals Co's E10 of €0.10 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jiangsu Hengrui Pharmaceuticals Co and its competitors. Jiangsu Hengrui Pharmaceuticals Co's current E10 is €0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Hengrui Pharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co (FRA:0BO) is currently considered Modestly Undervalued. The stock's GF Value™ is €7.14, compared to a current price of €6.35 — trading 11.1% below its estimated fair value. The current E10 is €0.10. Jiangsu Hengrui Pharmaceuticals Co's overall GF Score™ is 71/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Jiangsu Hengrui Pharmaceuticals Co (FRA:0BO), the current E10 is €0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jiangsu Hengrui Pharmaceuticals Co (FRA:0BO) Overvalued in 2026?

Based on GuruFocus' analysis, Jiangsu Hengrui Pharmaceuticals Co stock appears to be undervalued. The current stock price of €6.35 is trading 11.1% below its estimated GF Value™ of €7.14. GuruFocus considers Jiangsu Hengrui Pharmaceuticals Co to be Modestly Undervalued.

Key valuation signals for FRA:0BO:

  • E10: €0.10
  • GF Value™: €7.14 vs. price of €6.35 (11.1% below fair value)
  • GF Score™: 71/100 with 1 warning sign

No single metric tells the full story. See the FRA:0BO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jiangsu Hengrui Pharmaceuticals Co Business Description

Address No. 7, Kunlunshan Road, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222000
Jiangsu Hengrui Pharmaceuticals Co Ltd is a biopharmaceutical company that engages in the research, development, manufacture, and sale of drugs. It is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs, and anti-infection medications. The company specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system. Geographically, the company is segmented as Chinese mainland and Other countries generating majority revenue from the Chinese region.
71GF Score

Get the complete analysis for FRA:0BO

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.35
Price
€7.14
GF Value